Ultrastructure of fibrolamellar oncocytic hepatoma

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.

Fibrolamellar hepatoma (FL-HCC) is an uncommon variant of hepatocellular carcinoma (HCC), distinguished by histopathological features suggesting greater differentiation than conventional HCC. However, the optimal treatment and the prognosis of FL-HCC have been controversial. Follow-up studies are available from 1 year to 27 years, after 41 patients with FL-HCC were treated with partial hepatect...

Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver.

Fourteen patients with fibrolamellar hepatoma were treated with radical excision. In eight, a subtotal hepatic resection was performed from 16 months to more than 16 years ago. None of the patients have died and recurrences have been seen in only one patient. Six other patients had total hepatectomy and hepatic replacement. Two of these six patients have died of metastases and a third is living...

[Fibrolamellar hepatocellular carcinoma].

suppressor of oncocytic tumors

TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Materials and Methods 3.1. Tumor samples 3.2. Immunohistochemical staining and analysis 3.3. Analysis of mtDNA 4. Results and review of the literature 4.1 Renal oncocytoma 4.2 Thyroid oncocytoma 4.3 Parathyroid oncocytoma 4.4 Nasopharyngeal oncocytoma 4.5 Salivary gland oncocytoma 4.6 Adrenal gland oncocytoma 4.7 Pituitary gland oncocytoma 4.8 E...

Fibrolamellar Carcinoma: 2012 Update

Fibrolamellar carcinomas are a unique type of primary liver cancer. They occur most commonly in children and young adults. Their etiology remains a mystery, as they are not associated with chronic liver disease. Fibrolamellar carcinomas are not indolent tumors, but have an overall better prognosis than typical hepatocellular carcinomas, in part because of the younger age at presentation and the...